--- title: "Bank of America Securities Reaffirms Their Sell Rating on Lyell Immunopharma (LYEL)" type: "News" locale: "en" url: "https://longbridge.com/en/news/284887872.md" description: "Bank of America Securities analyst Jason Zemansky has reaffirmed a Sell rating on Lyell Immunopharma (LYEL) with a price target of $12.00. Zemansky, a 5-star analyst, has an average return of 21.3% and a 58.82% success rate. The overall analyst consensus for Lyell Immunopharma is a Moderate Buy, with an average price target of $36.80." datetime: "2026-05-01T10:47:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284887872.md) - [en](https://longbridge.com/en/news/284887872.md) - [zh-HK](https://longbridge.com/zh-HK/news/284887872.md) --- # Bank of America Securities Reaffirms Their Sell Rating on Lyell Immunopharma (LYEL) Bank of America Securities analyst Jason Zemansky maintained a Sell rating on Lyell Immunopharma today and set a price target of $12.00. ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Zemansky is a 5-star analyst with an average return of 21.3% and a 58.82% success rate. Zemansky covers the Healthcare sector, focusing on stocks such as Biogen, Cytokinetics, and BridgeBio Pharma. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Lyell Immunopharma with a $36.80 average price target. ### Related Stocks - [LYEL.US](https://longbridge.com/en/quote/LYEL.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [BIIB.US](https://longbridge.com/en/quote/BIIB.US.md) - [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md) - [BBIO.US](https://longbridge.com/en/quote/BBIO.US.md) - [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md) - [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md) - [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md) - [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md) - [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md) - [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md) - [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md) - [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md) - [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md) - [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md) - [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md) - [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md) - [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md) - [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md) - [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md) - [8648.JP](https://longbridge.com/en/quote/8648.JP.md) ## Related News & Research - [Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Tuesday](https://longbridge.com/en/news/285244886.md) - [Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Consensus Recommendation of "Hold" from Analysts](https://longbridge.com/en/news/282344009.md) - [Do Wall Street Analysts Like Arch Capital Stock?](https://longbridge.com/en/news/286783105.md) - [Are Wall Street Analysts Bullish on Seagate Technology Stock??](https://longbridge.com/en/news/286772566.md) - [This Analyst Just Upped the Price Target on Snowflake Stock. Here's Why.](https://longbridge.com/en/news/287069176.md)